Traders ( and some long term holders ) over exposed in AMRN seem to use any event driven pop in the PPS to unload . So unexpected near term catalysts ...figuring the EMA approval is largely priced in ? 1) GV sales stall as Hikma awaits GSK/Teva appeal 2) Brand Vascepa accelerates .....thx to CABG data and maybe the Covid data .
Anyone care to list other potential catalysts over next 3 mths ....EXCLUDING potential BO by BP